Header Logo

Deborah Hall

Concepts (382)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fragile X Syndrome
30
2023
192
7.990
Why?
Tremor
26
2022
117
7.330
Why?
Fragile X Mental Retardation Protein
32
2023
118
7.070
Why?
Ataxia
25
2022
78
6.320
Why?
Parkinson Disease
32
2023
844
5.780
Why?
Parkinsonian Disorders
11
2022
226
2.840
Why?
Heterozygote
11
2022
102
2.690
Why?
Trinucleotide Repeat Expansion
15
2023
46
2.490
Why?
Tinnitus
5
2020
12
2.060
Why?
Neurology
3
2022
58
1.900
Why?
Humans
109
2023
28395
1.790
Why?
Cognition Disorders
7
2021
1003
1.640
Why?
Research Design
6
2022
207
1.310
Why?
Female
62
2022
15704
1.300
Why?
Male
56
2022
15269
1.210
Why?
Supranuclear Palsy, Progressive
8
2020
28
1.190
Why?
Middle Aged
50
2022
9250
1.160
Why?
Gait Disorders, Neurologic
3
2020
138
1.160
Why?
Postural Balance
5
2020
122
1.140
Why?
Aged
46
2022
9256
1.120
Why?
Executive Function
3
2018
115
1.060
Why?
Gastrointestinal Microbiome
3
2023
181
1.040
Why?
Cerebellar Ataxia
2
2021
4
1.010
Why?
Trinucleotide Repeats
2
2018
11
0.980
Why?
Movement Disorders
4
2016
90
0.930
Why?
Cognition
6
2022
1352
0.900
Why?
Accidental Falls
4
2020
113
0.870
Why?
Biomedical Research
2
2018
66
0.830
Why?
Phenotype
9
2022
310
0.830
Why?
Exercise Therapy
3
2018
98
0.810
Why?
Attention
2
2020
131
0.770
Why?
Advance Care Planning
1
2022
12
0.770
Why?
Huntington Disease
1
2022
51
0.750
Why?
Mutation
8
2023
353
0.740
Why?
Spinocerebellar Degenerations
1
2021
4
0.730
Why?
Psychomotor Performance
2
2020
212
0.710
Why?
Patient Selection
2
2018
206
0.690
Why?
Cytidine Diphosphate Choline
1
2020
4
0.680
Why?
Nootropic Agents
1
2020
14
0.680
Why?
Delphi Technique
3
2022
27
0.660
Why?
Auditory Perception
2
2017
43
0.660
Why?
Walking
4
2020
259
0.650
Why?
Hearing
2
2021
21
0.610
Why?
Clinical Trials as Topic
2
2018
239
0.610
Why?
Case-Control Studies
10
2021
593
0.580
Why?
Acoustics
1
2017
19
0.570
Why?
Genetic Predisposition to Disease
5
2023
390
0.570
Why?
Dyskinesia, Drug-Induced
3
2023
21
0.570
Why?
Psychotherapy
1
2017
43
0.560
Why?
Deafness
3
2022
13
0.560
Why?
Polymerase Chain Reaction
2
2016
120
0.550
Why?
Memory Disorders
2
2016
162
0.540
Why?
Adult
23
2022
8097
0.540
Why?
Genetic Testing
6
2021
59
0.520
Why?
Cerebral Hemorrhage
4
2021
108
0.520
Why?
Severity of Illness Index
11
2020
985
0.510
Why?
Antipsychotic Agents
2
2023
65
0.510
Why?
Aged, 80 and over
17
2021
4851
0.500
Why?
DNA Methylation
1
2016
165
0.480
Why?
Treatment Outcome
11
2022
3615
0.470
Why?
Neuropsychological Tests
8
2022
1226
0.440
Why?
Quality of Life
6
2022
658
0.430
Why?
Acoustic Stimulation
1
2013
56
0.420
Why?
Surveys and Questionnaires
7
2022
1215
0.420
Why?
Speech Disorders
2
2020
11
0.390
Why?
Risk Factors
9
2021
2408
0.390
Why?
Deep Brain Stimulation
2
2022
39
0.380
Why?
Alleles
3
2020
221
0.380
Why?
United States
5
2022
2196
0.380
Why?
Retrospective Studies
10
2022
3609
0.370
Why?
Brain Ischemia
2
2021
63
0.370
Why?
Communication Disorders
1
2011
5
0.370
Why?
Chromosomes, Human, X
2
2009
10
0.350
Why?
Consensus
3
2022
98
0.350
Why?
Cochlear Implantation
2
2021
21
0.350
Why?
Gait
4
2020
412
0.350
Why?
Activities of Daily Living
4
2017
608
0.340
Why?
Dopamine
1
2010
87
0.340
Why?
Walking Speed
2
2022
40
0.340
Why?
Shoulder Pain
1
2010
57
0.340
Why?
Sex Chromosome Aberrations
1
2009
1
0.340
Why?
Chromosomes, Human, Y
1
2009
1
0.340
Why?
Speech Perception
2
2021
53
0.330
Why?
Levodopa
3
2023
47
0.330
Why?
Cognitive Dysfunction
2
2020
1065
0.320
Why?
DNA Repeat Expansion
2
2006
6
0.320
Why?
Quinolones
1
2009
13
0.320
Why?
Pilot Projects
3
2020
439
0.310
Why?
Motor Activity
3
2021
329
0.310
Why?
Cross-Sectional Studies
6
2020
932
0.300
Why?
Sex Factors
4
2022
475
0.300
Why?
Piperazines
1
2009
80
0.300
Why?
Students, Health Occupations
1
2007
5
0.280
Why?
Science
1
2007
4
0.280
Why?
Celiac Disease
1
2007
6
0.280
Why?
Dystonia
1
2007
15
0.280
Why?
Clinical Laboratory Techniques
1
2007
29
0.270
Why?
Fetal Distress
1
2006
1
0.270
Why?
Pregnancy in Diabetics
1
2006
3
0.270
Why?
RNA, Messenger
4
2023
308
0.270
Why?
Central Nervous System Agents
1
2006
7
0.270
Why?
Age of Onset
4
2016
99
0.270
Why?
Teaching
1
2007
62
0.270
Why?
Infant, Newborn, Diseases
1
2006
15
0.270
Why?
Pregnancy Complications, Cardiovascular
1
2006
15
0.270
Why?
Seizures
1
2006
65
0.260
Why?
Feces
2
2023
108
0.250
Why?
Gait Ataxia
1
2005
5
0.250
Why?
Prion Diseases
1
2005
2
0.250
Why?
Diagnostic Errors
1
2005
30
0.240
Why?
Cohort Studies
5
2023
1926
0.240
Why?
Glucosylceramidase
2
2022
17
0.240
Why?
Prions
1
2005
8
0.240
Why?
Disability Evaluation
5
2016
289
0.240
Why?
Brain
5
2022
1663
0.240
Why?
Time Factors
5
2020
1490
0.230
Why?
Exercise
3
2017
473
0.230
Why?
Intellectual Disability
1
2005
45
0.230
Why?
Hyperglycinemia, Nonketotic
1
2004
1
0.230
Why?
Neurotoxicity Syndromes
1
2004
3
0.230
Why?
Chorea
1
2004
5
0.230
Why?
Eye Movements
2
2021
11
0.230
Why?
Corpus Callosum
1
2003
12
0.210
Why?
Basal Ganglia Diseases
1
2023
6
0.210
Why?
Diffusion Magnetic Resonance Imaging
2
2021
94
0.210
Why?
Antiparkinson Agents
1
2023
66
0.210
Why?
Incidence
4
2020
773
0.210
Why?
Drug-Related Side Effects and Adverse Reactions
1
2023
21
0.210
Why?
Child
5
2022
1421
0.210
Why?
Fatty Acids, Volatile
1
2023
35
0.210
Why?
Caregivers
2
2022
203
0.210
Why?
Prebiotics
1
2023
24
0.210
Why?
Health Facilities
1
2022
22
0.200
Why?
ran GTP-Binding Protein
1
2022
3
0.200
Why?
Mental Disorders
1
2005
181
0.200
Why?
Career Mobility
1
2022
22
0.200
Why?
Homebound Persons
1
2022
6
0.200
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
22
0.200
Why?
Neurosecretory Systems
1
2022
9
0.200
Why?
Glucagon-Like Peptide 1
1
2022
11
0.200
Why?
Longitudinal Studies
3
2021
1384
0.200
Why?
Weather
2
2019
13
0.200
Why?
Mentoring
1
2022
31
0.200
Why?
Advance Directives
1
2022
3
0.200
Why?
Biomechanical Phenomena
4
2020
645
0.200
Why?
Cerebral Infarction
1
2003
148
0.190
Why?
Alzheimer Disease
1
2014
2118
0.190
Why?
Subthalamic Nucleus
1
2022
19
0.190
Why?
Documentation
1
2022
29
0.190
Why?
Dopamine Agents
1
2021
16
0.190
Why?
Multiple System Atrophy
1
2022
38
0.190
Why?
Food
1
2021
34
0.190
Why?
Primary Ovarian Insufficiency
1
2021
7
0.190
Why?
Comprehension
2
2016
30
0.190
Why?
Ovary
1
2021
21
0.180
Why?
Hearing Loss, Sensorineural
1
2021
13
0.180
Why?
Cerebral Amyloid Angiopathy
2
2019
113
0.180
Why?
Chicago
2
2021
939
0.180
Why?
Martial Arts
1
2020
4
0.180
Why?
Hyperglycemia
1
2020
32
0.180
Why?
Neurodegenerative Diseases
1
2022
124
0.180
Why?
Vision Disorders
1
2020
22
0.180
Why?
Menopause
1
2021
99
0.170
Why?
Societies, Medical
2
2019
154
0.170
Why?
Prevalence
2
2020
467
0.170
Why?
Hypertension
2
2019
244
0.170
Why?
Hearing Loss, Unilateral
1
2020
1
0.170
Why?
Hearing Aids
1
2020
3
0.170
Why?
Telemedicine
1
2022
119
0.170
Why?
Time and Motion Studies
1
2020
18
0.170
Why?
Blood Glucose
1
2020
108
0.170
Why?
Animals
5
2022
3780
0.170
Why?
Chemokine CCL5
1
2019
14
0.160
Why?
Dementia
1
2005
573
0.160
Why?
Th17 Cells
1
2019
30
0.160
Why?
Predictive Value of Tests
4
2020
492
0.160
Why?
Electroencephalography
2
2013
80
0.160
Why?
Academies and Institutes
1
2018
10
0.160
Why?
Research Subjects
1
2018
11
0.160
Why?
Sample Size
1
2018
20
0.160
Why?
Health Services Accessibility
1
2020
110
0.160
Why?
Dopaminergic Neurons
1
2019
50
0.150
Why?
Genotype
3
2016
359
0.150
Why?
Adolescent
4
2013
2307
0.150
Why?
Substantia Nigra
1
2019
124
0.150
Why?
Pedigree
3
2008
67
0.150
Why?
Independent Living
1
2021
318
0.150
Why?
High-Intensity Interval Training
1
2018
1
0.150
Why?
Gene-Environment Interaction
1
2018
18
0.150
Why?
Estrogens
1
2018
24
0.150
Why?
Prospective Studies
6
2021
1804
0.150
Why?
Ibuprofen
1
2017
12
0.150
Why?
Stakeholder Participation
1
2017
10
0.140
Why?
Endpoint Determination
1
2017
22
0.140
Why?
Patient Acceptance of Health Care
1
2018
81
0.140
Why?
Fatigue Syndrome, Chronic
1
2017
3
0.140
Why?
Colorado
2
2007
4
0.140
Why?
Memory, Short-Term
2
2015
100
0.140
Why?
Mosaicism
1
2016
9
0.140
Why?
Exercise Test
1
2018
122
0.140
Why?
Siblings
1
2016
16
0.140
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
111
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2018
185
0.130
Why?
Congresses as Topic
1
2016
31
0.130
Why?
Water Wells
1
2016
1
0.130
Why?
Uric Acid
1
2016
15
0.130
Why?
Epigenesis, Genetic
1
2016
86
0.130
Why?
Follow-Up Studies
4
2010
1858
0.130
Why?
Environmental Exposure
1
2016
17
0.130
Why?
Occupational Diseases
1
2016
21
0.130
Why?
Age Factors
4
2021
781
0.130
Why?
Computers
1
2015
20
0.130
Why?
Early Diagnosis
1
2015
67
0.130
Why?
Hip Prosthesis
1
2021
552
0.120
Why?
Chronic Disease
1
2017
441
0.120
Why?
Reaction Time
1
2015
106
0.120
Why?
DNA Mutational Analysis
2
2005
59
0.120
Why?
Monitoring, Physiologic
1
2015
76
0.120
Why?
Range of Motion, Articular
1
2018
704
0.120
Why?
Regression Analysis
1
2015
266
0.120
Why?
Young Adult
3
2013
2069
0.120
Why?
Endometrium
2
2002
7
0.120
Why?
Dopamine Agonists
2
2021
17
0.120
Why?
Breast Neoplasms
4
1997
409
0.110
Why?
Hyperkinesis
1
2013
8
0.110
Why?
Diagnosis, Computer-Assisted
1
2013
17
0.110
Why?
Auditory Pathways
1
2013
1
0.110
Why?
England
1
2013
12
0.110
Why?
Audiometry, Pure-Tone
1
2013
13
0.110
Why?
Psychoacoustics
1
2013
11
0.110
Why?
Diagnosis, Differential
2
2005
372
0.110
Why?
Cerebellar Diseases
1
2013
8
0.110
Why?
Registries
2
2022
188
0.110
Why?
Disease Progression
4
2016
717
0.110
Why?
Clinical Protocols
1
2013
60
0.110
Why?
Neuronal Plasticity
1
2013
47
0.100
Why?
Arthroplasty, Replacement, Hip
1
2021
821
0.100
Why?
Equipment Design
1
2013
152
0.100
Why?
Tamoxifen
1
1993
28
0.100
Why?
Breast
3
1998
26
0.100
Why?
Magnetic Resonance Imaging
3
2016
1143
0.100
Why?
Biopsy
2
2007
220
0.100
Why?
House Calls
2
2022
22
0.100
Why?
Double-Blind Method
1
2013
432
0.100
Why?
Neurologic Examination
3
2008
114
0.100
Why?
Infant, Newborn
2
2021
655
0.090
Why?
Genome-Wide Association Study
2
2023
283
0.090
Why?
Social Behavior Disorders
1
2011
5
0.090
Why?
Language Disorders
1
2011
7
0.090
Why?
Memantine
1
2010
9
0.090
Why?
Cyclohexanols
1
2010
18
0.090
Why?
Cocaine
1
2010
31
0.090
Why?
Mammography
4
1998
48
0.090
Why?
Point Mutation
2
2008
27
0.090
Why?
Odds Ratio
1
2011
268
0.090
Why?
Corpus Striatum
1
2010
65
0.090
Why?
Tomography, Emission-Computed, Single-Photon
1
2010
80
0.080
Why?
Herpes Zoster
1
2009
4
0.080
Why?
Atmospheric Pressure
2
2019
8
0.080
Why?
Brown-Sequard Syndrome
1
2009
4
0.080
Why?
Family Health
2
2007
36
0.080
Why?
Aripiprazole
1
2009
8
0.080
Why?
Atrophy
2
2008
93
0.080
Why?
Biomarkers
2
2022
596
0.080
Why?
Palate, Soft
1
2008
1
0.070
Why?
Alexander Disease
1
2008
1
0.070
Why?
Heredodegenerative Disorders, Nervous System
1
2008
2
0.070
Why?
Genetic Carrier Screening
1
2007
10
0.070
Why?
Exercise Tolerance
1
2007
32
0.070
Why?
Child, Preschool
1
2009
689
0.070
Why?
Glutens
1
2007
1
0.070
Why?
Jejunum
1
2007
12
0.070
Why?
Guidelines as Topic
1
2007
68
0.070
Why?
Chromosome Mapping
1
2007
44
0.070
Why?
Research Support as Topic
1
2007
14
0.070
Why?
National Institutes of Health (U.S.)
1
2007
25
0.070
Why?
Education
1
2007
46
0.070
Why?
North America
2
2018
43
0.070
Why?
Universities
1
2007
41
0.070
Why?
Carbidopa
1
2006
5
0.070
Why?
Peripheral Nervous System Diseases
1
2007
29
0.070
Why?
Cholinesterase Inhibitors
1
2006
15
0.070
Why?
Benzodiazepines
1
2006
48
0.070
Why?
Adrenergic beta-Antagonists
1
2006
29
0.070
Why?
Tomography, X-Ray Computed
2
2004
730
0.070
Why?
Internet
1
2007
98
0.060
Why?
Population Surveillance
1
2006
110
0.060
Why?
Intestinal Mucosa
1
2007
192
0.060
Why?
Syndrome
1
2005
82
0.060
Why?
Cerebellum
1
2005
46
0.060
Why?
Anxiety Disorders
1
2006
171
0.060
Why?
Pregnancy
1
2006
340
0.060
Why?
Health Surveys
1
2005
88
0.060
Why?
RNA-Binding Proteins
1
2004
25
0.060
Why?
Disease Models, Animal
2
2019
619
0.050
Why?
Linkage Disequilibrium
1
2023
44
0.050
Why?
Agraphia
1
2003
1
0.050
Why?
Dyslexia, Acquired
1
2003
1
0.050
Why?
Auditory Perceptual Disorders
1
2003
2
0.050
Why?
Genetic Loci
1
2023
51
0.050
Why?
Metagenome
1
2023
17
0.050
Why?
Nerve Tissue Proteins
1
2004
155
0.050
Why?
Uterine Diseases
1
2002
2
0.050
Why?
Mentors
1
2022
43
0.050
Why?
Guanine
1
2022
5
0.050
Why?
Endometriosis
1
2002
8
0.050
Why?
Task Performance and Analysis
2
2013
48
0.050
Why?
Polymorphism, Single Nucleotide
1
2023
284
0.050
Why?
Butyrates
1
2022
22
0.050
Why?
Neurons
1
2005
342
0.050
Why?
Stroke
1
2005
274
0.050
Why?
Dysbiosis
1
2022
56
0.050
Why?
Practice Guidelines as Topic
2
2021
320
0.050
Why?
Bacteria
1
2022
74
0.050
Why?
Peptides
1
2022
103
0.050
Why?
Genetic Background
1
2021
2
0.050
Why?
Physical Therapy Modalities
2
2012
75
0.050
Why?
Drosophila melanogaster
1
2021
15
0.050
Why?
Animals, Genetically Modified
1
2021
20
0.050
Why?
Fertility
1
2021
19
0.050
Why?
Cross-Over Studies
1
2021
63
0.050
Why?
Proteome
1
2021
42
0.050
Why?
Hydrogen-Ion Concentration
1
2021
149
0.040
Why?
Surface Properties
1
2021
140
0.040
Why?
Corrosion
1
2021
134
0.040
Why?
Life Style
1
2022
201
0.040
Why?
Materials Testing
1
2021
136
0.040
Why?
Inflammation
1
2022
284
0.040
Why?
Observational Studies as Topic
1
2020
19
0.040
Why?
Databases, Factual
1
2022
358
0.040
Why?
Noise
1
2020
31
0.040
Why?
Feasibility Studies
1
2020
231
0.040
Why?
Logistic Models
2
2018
395
0.040
Why?
Cochlear Implants
1
2020
28
0.040
Why?
Nerve Degeneration
1
2019
49
0.040
Why?
Biopsy, Needle
2
1996
108
0.040
Why?
Temperature
1
2018
66
0.040
Why?
Prosthesis Design
1
2021
498
0.040
Why?
Breast Diseases
1
1998
7
0.040
Why?
Risk Assessment
1
2021
676
0.040
Why?
Hospitalization
1
2020
323
0.040
Why?
Prognosis
1
2020
825
0.040
Why?
Mice, Inbred C57BL
1
2019
435
0.040
Why?
Comorbidity
1
2019
500
0.040
Why?
Prosthesis Failure
1
2021
536
0.030
Why?
Self Report
1
2018
221
0.030
Why?
Accelerometry
1
2017
88
0.030
Why?
Posture
1
2016
66
0.030
Why?
Protective Factors
1
2016
26
0.030
Why?
Occupational Exposure
1
2016
17
0.030
Why?
Radiography, Interventional
1
1996
23
0.030
Why?
Practice Patterns, Physicians'
1
1997
122
0.030
Why?
Neuroimaging
1
2016
128
0.030
Why?
Mice
1
2019
1461
0.030
Why?
Video Recording
1
2014
35
0.030
Why?
Single-Blind Method
1
2013
110
0.030
Why?
Movement
1
2013
117
0.030
Why?
Socioeconomic Factors
1
2013
308
0.020
Why?
Health Status
1
2013
224
0.020
Why?
Mental Health
1
2013
122
0.020
Why?
Statistics, Nonparametric
1
2011
128
0.020
Why?
Chi-Square Distribution
1
2011
146
0.020
Why?
Mass Screening
2
2007
182
0.020
Why?
Venlafaxine Hydrochloride
1
2010
17
0.020
Why?
Linear Models
1
2011
251
0.020
Why?
Drug Therapy, Combination
1
2010
183
0.020
Why?
Geniculate Ganglion
1
2009
1
0.020
Why?
Superior Cervical Ganglion
1
2009
1
0.020
Why?
Pons
1
2008
5
0.020
Why?
Intelligence
1
2008
19
0.020
Why?
Mental Processes
1
2008
19
0.020
Why?
Verbal Learning
1
2008
34
0.020
Why?
Glial Fibrillary Acidic Protein
1
2008
42
0.020
Why?
Gene Silencing
1
2007
25
0.020
Why?
Patient Compliance
1
2007
164
0.020
Why?
California
1
2004
32
0.010
Why?
Leiomyoma
1
2002
7
0.010
Why?
Uterine Neoplasms
1
2002
10
0.010
Why?
Ultrasonography
1
2002
243
0.010
Why?
Diagnostic Tests, Routine
1
1998
13
0.010
Why?
Age Distribution
1
1996
89
0.010
Why?
Palpation
1
1996
4
0.010
Why?
Hall's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (382)
Explore
_
Co-Authors (39)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_